As if UK Modern Slavery Act (MSA) compliance and the Falsified Medicines Directive (FMD) were not enough, Brexit carries enough uncertainty to keep even the most intrepid supply chain executives up at night. With the terms of a final trade deal still unclear it is easy to become paralysed by theOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.